Synucleozid hydrochloride（Cat No.:I045892）is an experimental small-molecule compound designed to modulate α-synuclein biology, a key protein implicated in Parkinson’s disease and other synucleinopathies. By interfering with α-synuclein aggregation and toxicity, it helps preserve neuronal function and reduce protein misfolding stress. Supplied as the hydrochloride salt, it offers improved solubility and handling for laboratory applications. Synucleozid hydrochloride is mainly used in neuroscience and neurodegeneration research, serving as a chemical probe to study disease mechanisms and to evaluate potential therapeutic strategies targeting protein aggregation and neuronal survival.